Fig. 5From: A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials studyReceiver operating characteristic (ROC) curve (a) and a histogram of prediction scores (b), visual of the separation between lung cancer and control subjects—the earlier clinical trial. a Shows receiver operating characteristic (ROC) curve; random changes for detecting cancer are plotted with a dashed line. b Shows a histogram of prediction scores; ranges of prediction scores that contain both cancer and control subjects have overlapping barsBack to article page